Researcher
Peter Attia
Last updated Sun May 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Background
Peter Attia trained in surgery (general surgical residency at Johns Hopkins) and worked on metabolic disease at McKinsey before founding a private longevity-medicine practice. He hosts The Drive, a long-form podcast covering exercise, nutrition, sleep, lipids, and longevity drugs.
Lines of work
Not a basic-science researcher; rather a translator and clinician focused on:
- Exercise prescription for healthspan, especially the zone-2 + resistance + stability framework popularised in Outlive.
- Lipidology — using apoB as the operational measure of atherogenic-particle burden; aggressive early management of cardiovascular risk.
- Cancer screening — advocating earlier and more sensitive screening protocols than guidelines call for, with discussion of cost and harm trade-offs.
- Nutrition and protein intake in older adults to preserve muscle mass.
- Off-label longevity-drug discussion, including rapamycin and metformin (with stated uncertainty about benefit).
Public profile
Outlive (2023) is the most widely-read recent popular book on the topic and frames an actionable approach to longevity-oriented preventive medicine. His public stance is more conservative about specific drugs than some longevity-adjacent influencers.
Affiliations / disclosures
Practises medicine privately and runs a paid membership for podcast listeners; product affiliations and financial relationships are listed on his site.
Related entries
References
- Attia, P. Outlive: The Science and Art of Longevity. Harmony Books (2023).